Cargando…

MAIT cells in metabolic diseases

BACKGROUND: Metabolic diseases represent a wide category of alterations affecting metabolism. These pathologies are notably marked by inflammation that implicates the immune system. Mucosal Associated Invariant (MAI)T cells are immune cells expressing a semi-invariant TCR able to recognize bacterial...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertrand, Léo, Lehuen, Agnès
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768571/
https://www.ncbi.nlm.nih.gov/pubmed/31500822
http://dx.doi.org/10.1016/j.molmet.2019.06.025
_version_ 1783455110258491392
author Bertrand, Léo
Lehuen, Agnès
author_facet Bertrand, Léo
Lehuen, Agnès
author_sort Bertrand, Léo
collection PubMed
description BACKGROUND: Metabolic diseases represent a wide category of alterations affecting metabolism. These pathologies are notably marked by inflammation that implicates the immune system. Mucosal Associated Invariant (MAI)T cells are immune cells expressing a semi-invariant TCR able to recognize bacterial and fungal vitamin B metabolites. MAIT cells can promote inflammation and are present in many organs central to metabolism, suggesting a role in the etiopathology of these diseases. SCOPE OF THE REVIEW: Here, we will review what is known of the involvement of MAIT cells in metabolic pathologies in humans and mice. MAJOR CONCLUSIONS: MAIT cells are severely affected, overactivated with a frequency reduction and a phenotype shift from protective to deleterious. Therefore, they might be a novel target to treat, in particular, pancreas and liver metabolic diseases.
format Online
Article
Text
id pubmed-6768571
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-67685712019-10-07 MAIT cells in metabolic diseases Bertrand, Léo Lehuen, Agnès Mol Metab Review BACKGROUND: Metabolic diseases represent a wide category of alterations affecting metabolism. These pathologies are notably marked by inflammation that implicates the immune system. Mucosal Associated Invariant (MAI)T cells are immune cells expressing a semi-invariant TCR able to recognize bacterial and fungal vitamin B metabolites. MAIT cells can promote inflammation and are present in many organs central to metabolism, suggesting a role in the etiopathology of these diseases. SCOPE OF THE REVIEW: Here, we will review what is known of the involvement of MAIT cells in metabolic pathologies in humans and mice. MAJOR CONCLUSIONS: MAIT cells are severely affected, overactivated with a frequency reduction and a phenotype shift from protective to deleterious. Therefore, they might be a novel target to treat, in particular, pancreas and liver metabolic diseases. Elsevier 2019-09-06 /pmc/articles/PMC6768571/ /pubmed/31500822 http://dx.doi.org/10.1016/j.molmet.2019.06.025 Text en © 2019 Published by Elsevier GmbH. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Bertrand, Léo
Lehuen, Agnès
MAIT cells in metabolic diseases
title MAIT cells in metabolic diseases
title_full MAIT cells in metabolic diseases
title_fullStr MAIT cells in metabolic diseases
title_full_unstemmed MAIT cells in metabolic diseases
title_short MAIT cells in metabolic diseases
title_sort mait cells in metabolic diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768571/
https://www.ncbi.nlm.nih.gov/pubmed/31500822
http://dx.doi.org/10.1016/j.molmet.2019.06.025
work_keys_str_mv AT bertrandleo maitcellsinmetabolicdiseases
AT lehuenagnes maitcellsinmetabolicdiseases